首页> 外文OA文献 >Rationale Ansätze zur Prozessentwicklung eines Anti-EGF-IL2-Fusionsproteins mittels einer rekombinanten BHK-Zelllinie
【2h】

Rationale Ansätze zur Prozessentwicklung eines Anti-EGF-IL2-Fusionsproteins mittels einer rekombinanten BHK-Zelllinie

机译:使用重组BHK细胞系开发抗EGF-IL2融合蛋白的合理方法

摘要

The main goal of this thesis was to development a sufficient process strategy for the production of an anti-EGFR-IL2-fusionprotein with a recombinant baby hamster kidney cell line (BHK). The thesis is integrated within a cooperation project with MERCK KGaA, Darmstadt. The classical process development part includes the investigation of process parameters regarding cell growth and product formation. The second part describes the new rational aspects for process development with the tool of metabolic flux analysis in mammalian cells.1. Classical process developmentLimitations of the main nutrients (glucose, glutamine, amino acids) and inhibitions of metabolites (lactate, ammonia) as well as cultivation parameters (osmolality, pH-value and pO2 content, cultivation temperature) were investigated. Therefore a new parallel spinner cultivation system for suspension cells with controlled conditions was used (cellferm-pro from DASGIP AG, Juelich), Within a cooperation project with DASGIP the tool “metabolic activity monitoring” was developed, established and used for parallel batch cultivations and compared regarding growth and productivity within this thesis. The reduction of the cultivation temperature from 37,0°C to 35,5°C led to an increase of 60% of the space time yield and 20% improvement of the maximum specific product forming rate was obtained. This positive effect was transferred successful to 2L stirred tank reactor scale (perfusion with bleeding). Several cultivation and reactor concepts were compared concerning the suitability for the cultivation of the recombinant BHK-cells. Therefore chemostat and perfusion modes with different cell retention systems in stirred tank reactors were investigated (STY in chemostat: 1.7mg/(L*d), perfusion with internal spinfilter 200mg/(L*d) and with ultrasonic cell retention 82mg/(L*d)).2. Rational bioprocess developmentThe quantification of the intracellular fluxes in mammalian cells in stationary conditions (metabolic flux analysis) generates new tasks for rational bioprocess development. It was necessary to show the proof of concept for the investigation of intracellular metabolic fluxes in mammalian cells and to develop a metabolic model for BHK-cells. This resulted in successful cultivation system and mode for stationary metabolic flux analysis (chemosat in stirred tank reactor) with optimized flux rate (D=0,02h-1) obtained performing a X-D-Diagram. Preparation of samples for obtaining of the 13C enrichment in proteinogenic amino acids with 2D-NMR was established. BHK metabolic model with 99 constrains was developed with implementation of the balance data and the relative 13C-Isotopomere distribution results. Successful modelling and calculation of the intracellular metabolic fluxes with regards to the compartimentation and exchange fluxes resulted in consistent metabolic flux estimations (error residuum 252).3. Applications for metabolic flux analysisThe positive results of the investigation conditions for intracellular metabolic flux analysis for mammalian cells and the development and use of the BHK metabolic model allows to present the evidence of practical applications of this tool for bioprocess development in several examples. Exchange fluxes of the anaplerotic reactions were quantified. Tasks of metabolic engineering in BHK-cells were investigated with BHK-cells expressed cytoplasmatic recombinant Pryruvat-Carboxylase (GBF, Braunschweig). Intracellular metabolic fluxes were obtained and also presented. The investigation of nucleotide metabolism with example of the pyrimidine thymdin enabled the quantification of the intracellular exchange fluxes of the serin-glycine and the C1-metabolism. Limitation within the purin metabolism with example of the hypoxanthine was identified with the tool of metabolic flux analysis, so that an optimized supplementation of hypoxanthine was developed. The adaptation of different model variations identified the influences of the mitochondrial transport systems on intracellular metabolic fluxes. The metabolic flux analysis allowed the balance of the fatty acid synthesis. The tool of metabolic flux analysis identified limitations within the fatty acid synthesis. Experiments with supplementations of fatty acids in batch cultivations documented significant improvements of the central metabolism as well as an increase of the recombinant protein production (100% increase of the STY and 50% respectively 100% increase of the specific productivity).
机译:本论文的主要目的是开发一种利用重组婴儿仓鼠肾细胞系(BHK)生产抗EGFR-IL2-融合蛋白的充分工艺策略。论文被整合到与达姆施塔特(Darmstadt)的MERCK KGaA的合作项目中。经典的工艺开发部分包括有关细胞生长和产物形成的工艺参数研究。第二部分介绍了利用哺乳动物细胞代谢通量分析工具进行过程开发的新的合理方面。1。经典工艺开发研究了主要养分(葡萄糖,谷氨酰胺,氨基酸)的限制和代谢产物(乳酸,氨)的抑制以及培养参数(重量克分子渗透浓度,pH值和pO2含量,培养温度)。因此,使用了用于条件受控的悬浮细胞的新型平行旋转培养系统(来自JuSG的DASGIP AG的cellferm-pro)。在与DASGIP的合作项目中,开发,建立了“代谢活性监测”工具,用于平行分批培养和在本文中比较了增长和生产率。栽培温度从37.0℃降低到35.5℃导致时空产率提高了60%,最大比产物形成率提高了20%。这种积极的作用成功地转移到了2L搅拌釜反应器规模上(充满出血的灌注)。比较了几种培养和反应器概念,涉及重组BHK细胞培养的适用性。因此,研究了搅拌釜反应器中具有不同细胞保留系统的化学恒温器和灌注模式(化学恒温器中的STY:1.7mg /(L * d),内部旋转过滤器200mg /(L * d)和超声细胞保留82mg /(L * d))。2。合理的生物过程发展固定条件下哺乳动物细胞内细胞通量的定量(代谢通量分析)为合理的生物过程发展产生了新的任务。有必要显示概念证据以研究哺乳动物细胞中的细胞内代谢通量,并建立BHK细胞的代谢模型。这样就产生了成功的培养系统和模式,用于固定代谢通量分析(搅拌釜反应器中的化肥),并通过X-D-图获得了优化的通量速率(D = 0,02h-1)。建立了用2D-NMR制备蛋白原氨基酸中13C富集样品的制备方法。利用平衡数据和相对13C-Isootopomere分布的结果,开发了具有99个约束的BHK代谢模型。关于隔室和交换通量的细胞内代谢通量的成功建模和计算导致一致的代谢通量估计(误差残差252)。3。代谢通量分析的应用哺乳动物细胞胞内代谢通量分析研究条件的积极结果以及BHK代谢模型的开发和使用,可以在几个示例中提供该工具在生物过程开发中的实际应用证据。定量了无反应性反应的交换通量。用BHK细胞表达的细胞质重组Pryruvat-羧化酶(GBF,不伦瑞克)研究了BHK细胞的代谢工程任务。获得并提出了细胞内代谢通量。以嘧啶胸腺嘧啶为例对核苷酸代谢的研究使得能够定量测定丝氨酸-甘氨酸和C1代谢的细胞内交换通量。利用代谢通量分析工具确定了嘌呤代谢在次黄嘌呤实例中的局限性,从而开发了次黄嘌呤的优化补充剂。不同模型变化的适应性确定了线粒体运输系统对细胞内代谢通量的影响。代谢通量分析允许脂肪酸合成的平衡。代谢通量分析工具确定了脂肪酸合成的局限性。分批培养中补充脂肪酸的实验表明,中心代谢显着改善,重组蛋白产量增加(STY分别提高了100%,比生产率分别提高了50%和100%)。

著录项

  • 作者

    Paul Wolfgang;

  • 作者单位
  • 年度 2006
  • 总页数
  • 原文格式 PDF
  • 正文语种 ger
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号